Evolus Inc buy stratec
Start price
20.05.19
/
50%
€14.97
Target price
24.10.20
€8.00
Performance (%)
-81.26%
End price
24.10.20
€2.81
Summary
This prediction ended on 24.10.20 with a price of €2.81. The BUY prediction by stratec for Evolus Inc performed very badly with a performance of -81.26%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evolus Inc | -4.783% | -4.783% | -63.193% | -44.204% |
| iShares Core DAX® | -0.681% | -4.853% | 1.940% | 54.334% |
| iShares Nasdaq 100 | -0.033% | 2.862% | 18.901% | 82.618% |
| iShares Nikkei 225® | -0.536% | -5.024% | 28.152% | 55.637% |
| iShares S&P 500 | -0.211% | 0.925% | 13.685% | 61.213% |
Comments by stratec for this prediction
In the thread Evolus Inc diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 20.05.2019 der Buy-Einschätzung von klostergang mit dem Kursziel 35$ zu.
Überschrift: Evolus obtained FDA approval for its product Jeuveau to treat patients with glabellar lines.
Es gibt keinen Handelsplatz
Kursziel geändert auf 8,0